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Abstract
Background: We aimed to assess health-related quality of life (HRQoL) among people with diabetes or
hypertension, estimate the effect of cardiovascular comorbidities on HRQoL as well as compare HRQoL in these
groups with that of healthy individuals.
Methods: A total of 9,070 respondents aged 18 years and over were assessed for HRQoL. Data were obtained
from the Croatian Adult Health Survey. Respondents were divided into five groups according to their medical
history: participants with hypertension (RR), hypertension and cardiovascular comorbidities (RR+), diabetes mellitus
(DM), diabetes and cardiovascular comorbidities (DM+) and participants free of these conditions (healthy
individuals, HI). HRQoL was assessed on 8 dimensions of the SF-36 questionnaire.
Results: Participants with diabetes and those with hypertension reported comparably limited (p > 0.05) HRQoL in
all dimensions of SF-36, compared with healthy individuals (p < 0.05). If cardiovascular comorbidities were present,
both participants with diabetes and participants with hypertension had lower results on all SF-36 scales (p > 0.05)
than participants without such comorbidities (p < 0.05). The results remained after adjustment for
sociodemographic variables (age, sex, employment, financial status and education).
Conclusion: Diabetes and hypertension seem to comparably impair HRQoL. Cardiovascular comorbidities further
reduce HRQoL in participants with both chronic conditions. Future research of interventions aimed at improving
these participants’ HRQoL is needed.
Background
One of the most important goals of all health interven-
tions is to improve the quality of life of persons affected
by disease [1]. In the domain of physical health and ill-
ness, quality of life refers to participant’s self-evaluation
of health or on their perceived functional status and
well-being [2]. In chronic conditions such as hyperten-
sion and diabetes, health-related quality of life (HRQoL)
is an especially important outcome, given their lifelong
nature and the need for daily self-management.
HRQoL has been found to be poorer in diabetic parti-
cipants than in the general population [1,3], especially in
the domains of self perceived physical health, while find-
ings on domains of psychosocial functioning vary
between studies [4-7]. Hypertension has also been
shown to be associated with negative outcomes in
HRQoL, especially in the domain of subjectively per-
ceived general health, although its impact on HRQoL is
usually less adverse than that of other chronic diseases
[4,8].
Although studies comparing the effects of different
chronic diseases generally point to a conclusion that
hypertension has less adverse effects on HRQoL than
diabetes, the magnitude and profile of differences
between diabetic and hypertensive participants in
HRQoL have not been determined as yet [9-11].
Epidemiological research of HRQoL in Croatia has so
far been conducted only for the general population [12],
while comprehensive research of HRQoL in Croatian
participants with chronic conditions is still lacking. As * Correspondence: tamara.poljicanin@idb.hr
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eases that affect the largest number of individuals and
lead to severe complications, the present study was
aimed at determining HRQoL in diabetic and hyperten-
sive participants, and to examining the effects of cardio-
vascular comorbidities on HRQoL in these chronic
conditions.
Methods
Participants
This survey was a part of the Croatian Adult Health
Survey (CAHS), a cross-sectional field survey conducted
by trained health care professionals in 2003. Data col-
lected in this study provided a comprehensive assess-
ment of health of Croatian residents, including their
HRQoL, access to and use of health care services, health
status and determinants such as smoking, physical activ-
ity, nutrition and alcohol use. The study was approved
by the Research Ethics Committee, Medical School, Uni-
versity of Zagreb, grant number 04-1060-2006. The
design of the CAHS is described in more detail else-
where [13].
Sampling
A total of 9,070 respondents aged 18 years and over
were assessed for HRQoL.
Respondents were divided into 5 groups: participants
with hypertension (RR) (I10; ICD-10), participants with
hypertension and cardiovascular co-morbidities (RR+),
participants with diabetes mellitus (DM) (E10-E14; ICD-
10), participants with diabetes and cardiovascular co-
morbidities (DM+) and individuals without these condi-
tions, i.e. healthy individuals (HI). Cardiovascular
comorbidities were defined as self-reported history of
angina (I20; ICD-10), myocardial infarction (I25.2; ICD-
10), heart insufficiency (I50; ICD-10) or stroke (I61, I63,
I64; ICD-10). Participants wi t hb o t hh y p e r t e n s i o na n d
diabetes were classified as DM+.
Instruments
HRQoL was assessed by SF-36, the Medical Outcome
Study short-form health survey [14-16]. The Croatian
version of the SF-36 questionnaire was prepared using a
standard translation procedure, followed by a pilot study
carried out in 1998 [12]. Psychometric characteristics of
this instrument have shown its adequate reliability and
validity [17].
The questionnaire contains 36 items integrated in
multi-item scales measuring eight generic health con-
cepts: physical functioning (PF), social functioning (SF),
role physical (RP), bodily pain (BP), mental health
(MH), role emotional (RE), vitality (VT), and general
health (GH).
Scoring included transformation of raw scores for
each subscale to a 0-100 scale, with higher scores repre-
senting better quality of life.
Statistical analysis
All statistical analyses were performed using SAS (ver-
sion 9.1.3). Descriptive analysis included calculations of
means, 95% confidence intervals (CI) of means and fre-
quencies of categorical variables. Distributions of catego-
rical sociodemographic predictors were compared using
chi-square tests, with a downward adjustment of statisti-
cal significance for multiple comparisons. The corrected
level of significance was obtained using Bonferroni cor-
rection, i.e. by dividing the defined p value (0.05) with
the number of comparisons made (n = 10). The adjusted
significant p value for multiple comparison of categori-
cal predictors was thus less than 0.005 (p < 0.005). The
level of significance of correlation between variables and
the correlation trend were analysed by Pearson Test.
The differences between groups and the impact of cate-
gorical sociodemographic variables were estimated by
MANOVA. Continuous sociodemographic variables
were controlled for by MANCOVA. All post-hoc com-
parisons were performed by Scheffe test. Statistical sig-
nificance was defined as p value less than 0.05 (p <
0.05).
Results
Participants’ sociodemographic characteristics are pre-
sented in Table 1. There were statistically significant dif-
ferences among different groups of participants and
healthy individuals in age (p < 0.001), level of education,
employment status and self-evaluation of financial status
(p < 0.001). Healthy individuals were younger, better
educated, more often employed and of better financial
status than participants with hypertension and/or dia-
betes. Among participants with hypertension and/or dia-
betes, those with cardiovascular comorbidities (DM+
and RR+) were older, less educated, less often employed
and of worse self-assessed financial status than partici-
pants without these comorbidities (DM and RR) (p <
0.001). The only insignificant differences were those for
self-assessed financial status among participants with
diabetes compared with participants who had cardiovas-
cular comorbidities (DM vs DM+ and DM vs RR+). Par-
ticipants with a matching status of comorbidities (RR vs
DM and RR+ vs DM+) did not differ in sociodemo-
graphic predictors. All groups consisted of more women
than men. There was a statistically significant difference
in sex (p < 0.001) between the groups without complica-
tions (DM and RR) with predomination of women with
hypertension, while the difference was insignificant (p =
0.073) between the groups with complications (DM+
and RR+).
Data on HRQoL are presented in Table 2. All dimen-
sions of SF-36 were significantly lower among partici-
pants with diabetes and/or hypertension than among
healthy individuals (p < 0.001). Groups with
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Page 2 of 6complications (DM+ and RR+) had poorer HRQoL on
all dimensions of SF-36 in comparison with the healthy
individuals (p < 0.001) as well as those without compli-
cations (DM and RR) (p < 0.05).
The studied groups differed significantly in all dimen-
sions of SF-36 (p < 0.001). In post-hoc analyses we found
that, regardless of diabetes or hypertension status, partici-
pants with comorbidities had comparable, significantly
poorer HRQoL than participants without comorbidities (p
< 0.001). Age showed small to medium correlations with
all dimensions of HRQoL (p < 0.05); when controlled for,
differences between the groups of participants with (DM+
and RR+) and those without comorbidities (DM and RR)
remained significant (p < 0.001), as well as differences
between healthy individuals (HI) and all other groups
(DM, DM+, RR, RR+). Adjusted data on HRQoL are also
presented in Table 2. Unemployment, lower self-evaluated
financial status and lower level of education were asso-
ciated with worse self-assessments of HRQoL in all sub-
groups of participants (p < 0.05).
Women had consistently lower scores on all dimensions
of SF-36 (p < 0.001), indicating poorer HRQoL. In the
groups without complications (DM and RR), stratified
analysis according to sex revealed poorer social function-
ing and more bodily pain (p < 0.05) in women with dia-
betes (DM) than in women with hypertension (RR), while
all other differences were insignificant (p > 0.05). There
were no significant differences between diabetic (DM) and
hypertensive (RR) men in any of the SF components.
All differences in HRQoL between participants with and
without comorbidities were clinically relevant, as they
were greater than 5 points on a 0-100 scale which is found
to be clinically significant [18]. Impairments in HRQoL
dimensions of participants with comorbidities were most
Table 1 Sociodemographic characteristics of the studied groups
HI (N = 5.043) RR (N = 1.490) RR+ (N = 1.564) DM (N = 231) DM+ (N = 742) p significant
differences
b
Age
a 46.5
(46.1-47.0)
60.1
(59.4-60.8)
65.3
(64.6-65.9)
60.0
(58.4-61.7)
65.7
(64.9-66.5)
< 0.001 RR&RR+, RR&DM+,
DM&DM+, DM&RR+,
HI&all other groups
Gender Male 32.8% 29.9% 28.7% 44.6% 32.3% < 0.001 DM&DM+, DM&RR+, RR
&DM, RR+&HI, DM&HI
Female 67.2% 70.1% 71.3% 55.4% 67.7%
Level of
education
Unfinished
primary
school
9.8% 24.2% 31,1% 16.0% 30.7% < 0.001 RR&RR+, RR&DM+,
DM&DM+, DM&RR+,
HI&all other groups
Primary
school
20.1% 26.9% 28.8% 28.6% 27.8%
High school
or similar
53.5% 37.4% 31.2% 43.3% 32.4%
College or
University
16.6% 11.5% 8,9% 12.1% 9.1%
Employed Yes 44.0% 22.3% 11.9% 21.2% 10.4% < 0.001 RR&RR+, RR&DM+,
DM&DM+, DM&RR+,
HI&all other groups
No 56.0% 77.7% 88.1% 78.8% 89.6%
Self-
evaluation of
financial
status
Poorer than
average
36.8% 45.0% 54.7% 45.4% 53.0% < 0.001 RR&RR+, RR&DM+,
RR&HI, RR+&HI, DM
+&HI
Average 50.2% 45.5% 39.3% 45.9% 40.4%
Better than
average
13.0% 9.5% 6.0% 8.7% 6.6%
Data are presented as proportion (%) unless noted otherwise;
a Mean (± 95% confidence interval)
b Pairs with significant differences between groups; post-hoc
analysis with downward adjustment for multiple comparison; Abbreviations: HI - healthy individuals, RR - participants with hypertension, RR+ - hypertension and
other cardiovascular comorbidities, DM - diabetes mellitus, DM+ - diabetes mellitus and cardiovascular comorbidities
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functioning (SF) and physical functioning (PF).
Discussion
Our results suggest that diabetes and hypertension have
comparably negative effects on HRQoL, which supports
the conclusion that both conditions impose similar self
perceived limitations in physical and mental functioning.
However, available literature [1] suggests that diabetes
in its early stages has no impact on perceived HRQoL of
the affected individuals, while our study found lower
scores on the majority of SF-36 dimensions, even in par-
ticipants without cardiovascular comorbidities. This
might suggest that assessing HRQoL may be beneficial
even in the early stages of treatment for diabetes and
hypertension.
In our study all dimensions of HRQoL were poorer in
people with diabetes and hypertension (DM and RR), as
well as in participants with cardiovascular complications
(DM+ and RR+), compared with healthy individuals
(HI). However, our data did not include information on
possible non-vascular comorbidities, such as retinopathy,
nephropathy or musculoskeletal disease, which have
been found to be important predictors of HRQoL in
diabetes [1,2,5]. It is likely that some individuals who
had been classified into the groups without cardiovascu-
lar comorbidities of hypertension or diabetes had other
comorbidities that potentially reduced their HRQoL. On
the other hand, even in the absence of any comorbid-
ities, a mere perception of being chronically ill and thus
frailer than a healthy person may also detrimentally
affect participant’s HRQoL [19,20].
We also observed that cardiovascular comorbidities
had a particularly negative impact on HRQoL in these
two chronic diseases. This is in line with previous
research which has found that the presence of macro-
vascular complications was a very important factor that
comparably limited participants’ HRQoL [1,2] to a clini-
cally significant extent [18] in both hypertension and
diabetes. Cardiovascular comorbidities are thought to
debilitate physical functioning to a higher degree than
hypertension or diabetes alone. This can be substan-
tiated by profiles of particular SF-36 scales, as self-
reported well-being in participants with comorbidities
has been shown to be poorest with respect to physical
functioning (RP and PF).
Previous studies have reported that diabetes and
hypertension negatively affect participants’ HRQoL
[4,5,21], and that heart disease worsened these partici-
pants’ HRQoL even further [6,22-27]. However, other
studies have yielded conflicting results on the severity of
impact of diabetes and hypertension on HRQoL [28,29],
without demonstrating whether the degree of impact of
cardiovascular comorbidities in these two conditions is
comparable.
Between-group comparisons of demographic charac-
teristics (level of education, employment status and self-
evaluation of financial status) in paired participant
groups (DM vs RR and DM+ vs RR+) did not reveal sta-
tistically significant differences. Although these
Table 2 The unadjusted and adjusted HRQoL indicators in the studied groups.
HI (N = 5,043) RR (N = 1,490) RR+ (N = 1,564) DM (N = 231) DM+ (N = 742) p
a
PF 81.5 (80.9-82.2) 66.6 (65.2-68.0) 47.8 (46.3-49.2) 65.1 (61.5-68.7) 49.9 (47.8-52.0) < 0.001
78.1 (76.8-79.5) 67.8 (66.0-69.7) 51.7 (49.7-53.7) 69.4 (65.4-73.4) 57.3 (54.6-60.0)
RP 77.5 (76.4-78.5) 58.1 (55.9-60.3) 33.5 (31.4-35.6) 56.1 (50.2-61.9) 35.9 (32.7-39.1) < 0.001
73.3 (71.1-75.5) 60.3 (57.3-63.3) 38.1 (34.8-41.3) 61.1 (54.6-67.7) 43.4 (39.0-47.8)
BP 74.5 (73.7-75.3) 62.1 (60.7-63.6) 48.5 (47.1-50.0) 58.7 (54.9-62.5) 49.4 (47.2-51.6) < 0.001
72.8 (71.2-74.3) 65.5 (63.4-67.6) 52.7 (50.3-57.0) 62.9 (58.3-67.6) 54.0 (50.9-57.1)
GH 64.2 (63.6-64.8) 51.6 (50.6-52.6) 40.2 (39.2-41.1) 49.0 (46.3-51.7) 39.2 (37.8-40.6) < 0.001
62.9 (61.8-64.0) 53.2 (51.7-54.7) 43.7 (42.1-45.3) 52.7 (49.5-55.9) 41.7 (39.6-43.9)
VT 60.7 (60.1-61.2) 53.2 (52.2-54.2) 39.8 (38.7-40.9) 51.4 (48.5-54.3) 41.3 (39.7-43.0) < 0.001
59.1 (57.9-60.2) 55.4 (53.9-57.0) 44.4 (42.7-46.1) 55.0 (51.7-58.4) 46.5 (44.2-48.7)
SF 82.0 (81.4-82.7) 74.4 (73.1-75.6) 58.7 (57.2-60.2) 69.2 (65.6-72.8) 59.8 (57.6-61.9) < 0.001
79.2 (77.8-80.6) 76.1 (74.2-78.0) 62.7 (60.6-64.8) 73.9 (69.8-78.1) 64.7 (61.9-67.4)
RE 79.9 (78.9-80.9) 69.3 (67.1-71.4) 51.4 (49.1-53.7) 70.4 (64.9-76.0) 51.5 (48.1-54.9) < 0.001
76.6 (74.3-78.8) 72.6 (69.5-75.7) 57.1 (53.7-60.5) 74.7 (67.9-81.4) 58.8 (54.2-63.3)
MH 68.3 (67.8-68.8) 62.5 (61.5-63.4) 52.8 (51.7-53.8) 60.6 (58.1-63.2) 53.7 (52.1-55.3) < 0.001
66.8 (65.7-67.8) 64.0 (62.6-65.5) 57.8 (56.2-59.4) 63.4 (60.2-66.5) 58.1 (56.0-60.2)
Data are presented as mean (± 95% confidence interval); adjusted results are in italic format;
a post-hoc analysis showed significant differences between RR&RR+,
RR&DM+, DM&DM+, DM&RR+ and HI& all other groups (RR, RR+, DM, DM+) in all SF-36 dimensions; Scheffe test, p < 0.001; Abbreviations: HI - healthy
individuals, RR - participants with hypertension, RR+ - hypertension and other cardiovascular comorbidities, DM - diabetes mellitus, DM+ - diabetes mellitus and
cardiovascular comorbidities, PF - physical functioning, RP - role physical, BP - bodily pain, GH - general health, VT - vitality, SF - social functioning, RE - role
emotional, MH - mental health.
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be presumed to have been comparable in the groups
with complications (DM+ and RR+), as well as in those
without complications (DM and RR). Taking into
account the differences in sex between the groups with-
out complications (DM and RR), we analysed both sexes
separately and found differences in social functioning
and bodily pain, but only in women. In view of these
r e s u l t sa n do ft h ef a c tt h a tH R Q o Lw a ss i m i l a r l y
affected in the pairs of groups with complications (DM+
and RR+) and in those without them (DM and RR) even
after age was controlled for, we conclude that the
observed differences are attributable to chronic condi-
tions rather than to possible sociodemographic confoun-
ders analysed in this study.
Our results confirm previous reports of adverse
impacts of diabetes and hypertension on participants’
well-being and functioning. The novelty of our study is
that it shows these effect sizes are comparable. This is a
useful finding for clinical practice, particularly in the
early treatment of diabetes and hypertension, at which
point improvement in self-management and conse-
quently HRQoL is still possible. Our results also contri-
bute to transcultural research of HRQoL in diabetes and
hypertension, as research on this issue in transitional
countries has been scarce.
Limitations of our study include the self-reported nat-
ure of the CAHS data, and that more detailed informa-
tion on disease duration, adherence to treatment, and
non-vascular concomitant diseases were unavailable.
However, all data were collected by trained medical pro-
fessional, which could provide some certainty that medi-
cal conditions studied were recognized and classified
properly.
Conclusions
Our results showed an adverse impact of both diabetes
and hypertension on participants’ well-being and func-
tioning, adding to current knowledge by the finding that
the effect sizes are comparable, at least in the Croatian
adult population. This could be useful in clinical prac-
tice, particularly in early treatment of diabetes and
hypertension, at which point improving self-manage-
ment and consequently HRQoL is still possible. We also
found that cardiovascular comorbidities have a marked
negative impact on HRQoL in people with both these
conditions.
Early recognition of participants with these chronic
diseases might therefore be considered to be of impor-
tance, not only in clinical disease management, but also
in participant education and empowerment aimed at
improving their HRQoL. Further research on appropri-
ate interventions aimed at HRQoL of these participants
is needed.
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